Communiqués Cell Impact AB

Actions

CI

SE0025940513

Machines et équipements industriels

PEA

Marché Fermé - Nasdaq Stockholm 18:00:00 14/08/2026			Varia. 5j.	Varia. 1 janv.
0,0568 ^SEK	+2,90 %		+0,53 %	-64,72 %

05/08	Cell Impact AB (publ) publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
02/07	Cell Impact : départ de la directrice financière d'ici fin septembre	MT

Communiqués

11:29	Cell Impact's CEO, Daniel Vallin, has conducted a CEO interview with Mangold Insight	AQ
13/08	Members of the company's Board of Directors and management subscribe for units in Cell Impact's ongoing rights issue of units	AQ
06/08	The subscription period in Cell Impact's rights issue of units starts today	AQ
05/08	Cell Impact Q2 2026: Progress continues despite prolonged lead times	AQ
31/07	Communiqué from the Extraordinary General Meeting of Cell Impact AB (publ)	AQ
02/07	CFO Malin Lundberg to leave Cell Impact	AQ
29/06	NOTICE OF THE EXTRAORDINARY GENERAL MEETING OF CELL IMPACT AB (PUBL)	AQ
29/06	Cell Impact resolves on a rights issue of units of approximately SEK 53.6 million and procures a bridge loan of SEK 15 million	AQ
27/06	Cell Impact receives order worth SEK 5.3 million	AQ
17/06	Cell Impact reports limited liquidity following delayed transaction	AQ
13/05	Cell Impact : 2026 Q1 Interim Report	PU
13/05	Cell Impact Q1 2026: Measured progress in a turbulent hydrogen market	AQ
23/04	Communiqué from the Annual General Meeting 2026 of Cell Impact AB (publ)	AQ
06/03	Last day of trading in Cell Impact BTA - conversion of BTA into shares	AQ
04/03	Cell Impact carries out a directed share issue to guarantors and a directed issue of warrants to lender	AQ
25/02	Cell Impact in replacement agreement, receives 6 MSEK	AQ
24/02	Cell Impact announces outcome of rights issue	AQ
05/02	Cell Impact publishes information document regarding the rights issue	AQ
04/02	Cell Impact : 2025 Q4 Year-end Report	PU
04/02	Cell Impact Q4 2025: Growth and expansion of the business paving the way forward	AQ
30/01	Communiqué from the Extraordinary General Meeting of Cell Impact AB (publ)	AQ
22/12	Notice of the extraordinary general meeting of Cell Impact AB (publ)	AQ
22/12	Cell Impact resolves on a rights issue of approximately SEK 38.3 million, secures a bridge loan, and diversifies its operations toward additional industrial segments	AQ
09/12	Cell Impact to deliver tool to leading automotive manufacturer	AQ
21/11	Cell Impact named Europe's flow plate manufacturer of the year	AQ